Related Experiment Videos
Electrophoresis of BRCA1 oncosuppressor
D Bernard-Gallon1, F De Oliveira, D Favy
1Laboratoire d'Oncologie Moleculaire, INSERM CRI 9502 and EA 2145, Centre Jean Perrin, 63011 Clermont-Ferrand Cedex 1, France.
Abstract:
BRCA1 is a familial breast and ovarian cancer susceptibility gene and encodes proteins that function as tumor suppressors in human breast cancer cells. To elucidate the biological function of BRCA1, knowledge of cellular localization is needed. This can be achieved by using specific antibodies, so in a first step, we characterized by Western blot analysis the rabbit polyclonal antibodies (K-18) and (D-20) raised against the amino-terminus of human BRCA1 protein, and the polyclonal antibodies (C-20) and (I-20) raised against the carboxy terminus of human BRCA1 protein. The 220-kDa band corresponding to BRCA1 protein was recognized by the four tested antibodies in two mammary carcinoma cell lines (HBL100 and MCF7).
Insights
Researchers validated four antibodies for detecting the BRCA1 protein, a key tumor suppressor in breast and ovarian cancers. This crucial step enables further studies into BRCA1
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- BRCA1 is a critical tumor suppressor gene linked to familial breast and ovarian cancers.
- Understanding BRCA1's cellular localization is essential for elucidating its biological function.
- Specific antibodies are required for detecting and localizing BRCA1 protein within cells.
Purpose of the Study:
- To characterize the specificity and efficacy of four novel polyclonal antibodies against human BRCA1 protein.
- To validate these antibodies for use in Western blot analysis for BRCA1 detection.
Main Methods:
- Western blot analysis was employed to test four rabbit polyclonal antibodies (K-18, D-20, C-20, I-20) against human BRCA1.
- Antibodies were raised against both the amino- and carboxy-termini of the BRCA1 protein.
- The antibodies were tested using two human mammary carcinoma cell lines: HBL100 and MCF7.
Main Results:
- All four tested antibodies (K-18, D-20, C-20, I-20) successfully recognized the expected 220-kDa band corresponding to the BRCA1 protein.
- Consistent detection of the BRCA1 protein was observed in both HBL100 and MCF7 cell lines.
- This indicates the suitability of these antibodies for detecting BRCA1 in mammary carcinoma cells.
Conclusions:
- The characterized antibodies are effective tools for detecting human BRCA1 protein via Western blot.
- These validated antibodies will facilitate future research into BRCA1's cellular localization and function.
- This study provides a foundational step for investigating BRCA1's role in breast cancer pathogenesis.